Insider trade

Viemed Healthcare (VMD)Director sold ~$239K

Nitin Kaushal, Director at Viemed Healthcare, sold ~$239K of Viemed Healthcare shares.

~$239K
Approx. value · 34K sh @ $7.01
127K
Holds after · shares reported
Traded
Jun 27, 2025
Filed
Jun 30, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 26, 2025InsiderDirector sold ~$62K of VMD shares in the open market
  2. Jun 27, 2025 · this disclosureInsiderDirector sold ~$239K of VMD shares in the open market

What came next

  1. Jun 27, 2025InsiderOfficer sold ~$24K of VMD shares in the open market
  2. Jun 30, 2025Insider · 2 peopleInsiders: 3 sales (~$1.3M)
  3. Aug 12, 2025InsiderOfficer sold ~$367K of VMD shares in the open market
  4. Aug 13, 2025Insider · 1 personInsiders: 2 sales (~$36K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Viemed Healthcare

OQRO holds no insider, Congress, fund or contract record for Viemed Healthcare dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VMD page.

Other recent filings by Nitin Kaushal, Director

The full history of Nitin Kaushal, Director is on the profile page.

How this filing works

Other disclosures at Viemed Healthcare

Everything OQRO holds on this company is on its VMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data